Increased concanavalin A-dependent agglutinability of mouse fibroblasts after treatment with leukocyte lysosomal preparations.
D000371:Agglutination / Q000187:drug effects; D000818:Animals; D001798:Blood Proteins / Q000032:analysis; D002850:Chromatography, Gel; D003080:Cold Temperature; D003208:Concanavalin A / Q000494:pharmacology; D003260:Contact Inhibition / Q000187:drug effects; D005347:Fibroblasts / Q000187:drug effects*; D006027:Glycosides / Q000494:pharmacology; D006358:Hot Temperature; D006801:Humans; D037102:Lectins / Q000494:pharmacology*; D007962:Leukocytes / Q000166:cytology / Q000201:enzymology; D008247:Lysosomes / Q000032:analysis; D051379:Mice; D010196:Pancreatic Elastase; D010455:Peptides / Q000494:pharmacology; D014020:Tissue Extracts / Q000494:pharmacology*
D001798:Blood Proteins; D006027:Glycosides; D037102:Lectins; D010455:Peptides; D014020:Tissue Extracts; D003208:Concanavalin A; D010196:Pancreatic Elastase